Motley Fool Wealth Management LLC Cuts Position in HealthEquity, Inc. (NASDAQ:HQY)

Motley Fool Wealth Management LLC cut its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 1.2% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 139,580 shares of the company’s stock after selling 1,655 shares during the quarter. Motley Fool Wealth Management LLC’s holdings in HealthEquity were worth $9,262,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. FMR LLC grew its stake in shares of HealthEquity by 19.1% during the third quarter. FMR LLC now owns 5,648,992 shares of the company’s stock valued at $412,659,000 after acquiring an additional 907,743 shares in the last quarter. Clearbridge Investments LLC grew its stake in shares of HealthEquity by 12.1% in the third quarter. Clearbridge Investments LLC now owns 2,204,675 shares of the company’s stock worth $161,051,000 after purchasing an additional 238,116 shares in the last quarter. Mackenzie Financial Corp lifted its holdings in HealthEquity by 58.2% in the fourth quarter. Mackenzie Financial Corp now owns 1,807,407 shares of the company’s stock worth $119,831,000 after purchasing an additional 664,979 shares during the period. Van Berkom & Associates Inc. increased its stake in shares of HealthEquity by 5.2% during the third quarter. Van Berkom & Associates Inc. now owns 1,042,470 shares of the company’s stock valued at $76,152,000 after acquiring an additional 51,824 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its stake in HealthEquity by 2.8% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 980,517 shares of the company’s stock valued at $71,627,000 after purchasing an additional 26,868 shares in the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the company. Barrington Research reissued an “outperform” rating and issued a $100.00 price objective on shares of HealthEquity in a research note on Friday, March 22nd. Barclays lifted their price target on HealthEquity from $84.00 to $104.00 and gave the company an “overweight” rating in a report on Friday, February 23rd. JMP Securities began coverage on HealthEquity in a research report on Thursday, April 4th. They issued a “mkt outperform” rating and a $101.00 price target for the company. BTIG Research boosted their target price on HealthEquity from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Wednesday, March 20th. Finally, JPMorgan Chase & Co. lifted their target price on shares of HealthEquity from $86.00 to $108.00 and gave the stock an “overweight” rating in a report on Tuesday, April 2nd. One equities research analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, HealthEquity currently has a consensus rating of “Moderate Buy” and a consensus price target of $96.17.

Insider Activity at HealthEquity

In other news, EVP Delano Ladd sold 2,499 shares of the stock in a transaction that occurred on Friday, February 9th. The stock was sold at an average price of $80.00, for a total value of $199,920.00. Following the completion of the sale, the executive vice president now owns 49,996 shares of the company’s stock, valued at approximately $3,999,680. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other HealthEquity news, EVP Delano Ladd sold 2,499 shares of the business’s stock in a transaction that occurred on Friday, February 9th. The stock was sold at an average price of $80.00, for a total transaction of $199,920.00. Following the transaction, the executive vice president now owns 49,996 shares of the company’s stock, valued at $3,999,680. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director Evelyn S. Dilsaver sold 32,500 shares of the firm’s stock in a transaction that occurred on Tuesday, March 26th. The shares were sold at an average price of $79.29, for a total value of $2,576,925.00. Following the completion of the sale, the director now directly owns 32,123 shares of the company’s stock, valued at $2,547,032.67. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 71,322 shares of company stock valued at $5,682,895. Insiders own 2.70% of the company’s stock.

HealthEquity Trading Up 1.5 %

NASDAQ HQY traded up $1.22 during trading hours on Friday, hitting $80.26. The company’s stock had a trading volume of 382,417 shares, compared to its average volume of 551,039. The stock has a fifty day moving average of $81.01 and a 200 day moving average of $74.49. The company has a quick ratio of 4.76, a current ratio of 4.76 and a debt-to-equity ratio of 0.43. HealthEquity, Inc. has a twelve month low of $48.86 and a twelve month high of $84.49. The firm has a market capitalization of $6.89 billion, a P/E ratio of 125.41, a PEG ratio of 1.31 and a beta of 0.53.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Tuesday, March 19th. The company reported $0.50 earnings per share for the quarter, topping the consensus estimate of $0.42 by $0.08. The company had revenue of $262.39 million for the quarter, compared to analyst estimates of $258.56 million. HealthEquity had a net margin of 5.57% and a return on equity of 6.91%. Equities research analysts forecast that HealthEquity, Inc. will post 2.12 earnings per share for the current fiscal year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.